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Patients with congenital aortic stenosis (AS) have a broad
clinical spectrum, ranging from critically-ill newborns to
asymptomatic adults. Combined Doppler and 2-dimensional
echocardiographic assessment of critical neonatal AS was
introduced 30 years ago (1). Since then, evaluation of disease
severity in a youngAS patient has been primarily on the basis of
symptoms and echocardiographic parameters (2), but echo-
cardiographic measurements are only the tip of the iceberg
when assessing the impact of AS on the myocardium itself.See page 1778The common denominator in AS is chronic pressure
load on the left ventricle (LV). Concentric hypertrophy
develops as the LV attempts to normalize wall stress, but
LV remodeling with ﬁbrosis can occur (3,4). Historically,
the only way to directly assess ﬁbrosis has been by biopsy,
which may not be representative of the entire LV and is
impractical in the clinical setting. One instead evaluates the
consequences of ﬁbrosis using surrogate echocardiographic
parameters. In adult AS patients, there are correlations
among LV dysfunction, ventricular ﬁbrosis, and poorer
prognosis (3,5–7). Children with AS post-intervention may
have symptoms, diastolic dysfunction, and ﬁbrosis despite
“adequate” relief of obstruction (2,8,9); whether ﬁbrosis in
childhood AS correlates with prognosis is unclear, and
ﬁndings from adults cannot be extrapolated to children for
2 reasons. First, although the etiology of AS in older adults
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be quite different than in adults (11). For example, in some
cases of prenatally-diagnosed severe AS, the LV involutes
over a few weeks from a dilated, poorly-contracting cavity
into a ﬁbrotic shell. If AS is relieved through fetal inter-
vention by balloon valvuloplasty, development of hypopla-
stic left heart syndrome can potentially be prevented (12).
Focal Ventricular Fibrosis and
Cardiac Magnetic Resonance
Cardiac magnetic resonance (CMR) has recently been
promoted as a noninvasive technique to directly assess
ventricular ﬁbrosis in lieu of biopsy. Focal ﬁbrosis can
be detected by CMR as areas of increased signal intensity
on post-contrast late gadolinium enhancement (LGE)
imaging, with LGE pattern depending on the etiology of
ﬁbrosis (4). The degree of focal ﬁbrosis detected by LGE
in older adults with AS has been shown to correlate with
histologic ﬁbrosis and poorer outcome post-intervention
(5,13). Circumferential subendocardial LGE consistent
with endocardial ﬁbroelastosis has also been described in
young congenital AS patients and conﬁrmed on pathology
(14,15). The 4 cases reported by Robinson et al. (15) are
particularly intriguing, as these teenagers all had remote,
“successful” procedures to relieve severe AS, but each pre-
sented with symptomatic diastolic heart disease.
Diffuse Fibrosis and CMR
Because LGE is on the basis of nulling “normal”myocardium
to demonstrate a difference in signal intensity between normal
and ﬁbrotic regions, LGE imaging is insensitive to diffuse
ﬁbrosis. Recently, a CMR T1 mapping technique was in-
troduced to assess diffuse myocardial ﬁbrosis by measuring
myocardial and blood pool longitudinal relaxation time (T1)
before and after gadolinium contrast (16), with changes in T1
values used to calculate extracellular volume fraction (ECV)
(17). CMR-derived ECV has been shown to correlate with
myocardial ﬁbrosis in animal models (18) and in older adults
with cardiovascular diseases (4) including AS (19).
The paper by Dusenbery et al. (20) in this issue of the
Journal is the ﬁrst study reporting the use of CMR-derived
ECV to measure diffuse LV ﬁbrosis in young subjects with
congenital AS and to explore the relationship between CMR-
derived measures of ﬁbrosis and clinical and echocardio-
graphic data. In this retrospective, case-control study, the
authors compared ECV measured by CMR in 35 children
and young adults with congenital AS with ECV measure-
ments in 27 normal controls. They found that mean ECV
(i.e., degree of diffuse ﬁbrosis) was higher in the AS patients
versus control subjects, but there was signiﬁcant overlap be-
tween the 2 groups such that only 37% of congenital AS
patients had abnormal ECV. LGE was observed in about
one-fourth of the AS patients. Both ECV and LGE were
associated with abnormal echocardiographic diastolic
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1787function indexes but not with current AS gradient or with LV
diastolic assessment in those patients with contemporaneous
catheterization data. As this was a retrospective study, not
all AS patients had complete echocardiograms, catheteriza-
tion, or exercise tests within 1 year of CMR. Also, although
the patients were a heterogeneous group, this group may not
be representative of the spectrum of congenital AS patients, as
only those referred for CMR were included. Eighty percent
of their patients had undergone prior interventions, only
one-half were below 16 years of age at the time of CMR, and
83%weremale. Despite these limitations, this study conﬁrms
that myocardial ﬁbrosis can persist despite what appears to
be adequate relief of obstruction in young congenital AS
patients, as has previously been found in older adults.
Moreover, this study demonstrates the feasibility of ECV
assessment in children.
T1 mapping is a potentially very powerful technique, but
further validation and standardization is needed (4,18,21).
There are currently several T1 mapping methods; T1 maps
generated by 1 method may not be equivalent to those
generated by another. T1 mapping may be inﬂuenced by
several technical factors, including gadolinium dose and
wash-in/wash-out dynamics, heart rate and motion, and
magnet strength. There are also patient-speciﬁc variables
such as age, size, sex, and genetic heterogeneities that may
affect T1 measurement.
After this CMR T1 mapping technique is validated and
standardized, it could potentially be used to monitor disease
progression and/or regression and optimize management of
congenital AS patients. One could theoretically use CMR to
investigate whether there is a vulnerable period in cardiac
development when the myocardium is particularly sensitive to
pressure overload or to develop therapeutics directly targeting
reversible ﬁbrosis (22). It is also possible that other CMR
techniques will help deﬁne ventricular response to congenital
AS. For example, diffusion tensor MRI has recently been used
to demonstrate “developmental plasticity” in cardiomyocyte
architecture between fetal, neonatal, and adult periods (23).
Perhaps soon T1 mapping and other CMR techniques will be
ready for “prime time,” 30 years down the road of noninvasive
imaging for congenital AS.
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